Table 4. .
Results of Functional Studies |
|||||||
Variant | Sequence | n | Known or Novel | alpha-MSH Activation (EC50) | Basal Activity | Summary | Family Segregation Data |
S30F | tgagt[c/t]ccttg | 1 | Known185 | Not tested alone182 | Not tested alone182 | … | Not tested |
G32E | ccttg[g/a]aaaag | 1 | Novel | .3 nM | 70% | Minor | Figure 3A |
E61K | tgttg[g/a]agaat | 1 | Novel | Low | ⩽10% | Severe | Figure 3B |
S127L | tgact[c/t]ggtga | 1 | Known182 | 29 nM | 80% | Intermediate | Figure 3C |
L211Dela | ttct[ctct/-]atgt | 2 | Known175 | Truncated receptor | Truncated receptor | Severe | Figure 3D |
P299Ha | cgatc[c/a]tctga | 2 | Known182 | Negative | ⩽10% | Severe | Figure 3E |
A303T | tttat[g/a]cactc | 1 | Novel | Low | ⩽10% | Severe | Figure 3F |
C326R | gcctt[t/c]gtgac | 1 | Novel | .4 nM | 150% | Minor | Figure 3G |
Wild type | … | … | … | .3 nM | 100% | … | … |
Individuals who had the L211Del also had the P299H variant.